Results 111 to 120 of about 34,386 (239)
AIDS Research and Therapy, 2019 Background Human herpes virus 8 (HHV8) is the causative agent of Kaposi’s sarcoma and has been associated with an increasing number of hematologic diseases such as primary effusion lymphoma (PEL) (both classic and extracavitary form), multicentric ...
Laura Campogiani +9 more
doaj +1 more source
Tumor type M2-pyruvate-kinase levels in pleural fluid versus plasma in cancer patients: a further tool to define the need for invasive procedures [PDF]
, 2008 Pleural effusion is a common diagnostic problem and a challenge to the thoracic surgeon. The analysis of serum and body fluids for tumor markers is an established diagnostic procedure.
Cortese, C +6 more
core +1 more source
Protein glycosylation in lung cancer from a mass spectrometry perspective
Mass Spectrometry Reviews, Volume 45, Issue 3, Page 455-475, May/June 2026.ABSTRACT Lung cancer is a severe disease for which better diagnostic and therapeutic approaches are urgently needed. Increasing evidence implies that aberrant protein glycosylation plays a crucial role in the pathogenesis and progression of lung cancer.
Mirjam Balbisi +2 more
wiley +1 more source
A Review of KSHV/HHV8-Associated Neoplasms and Related Lymphoproliferative Lesions
LymphaticsThere has been extensive research on the KSHV/HHV8 virus, which has led to a better understanding of viral transmission, pathogenesis, viral-driven lymphoid proliferation, neoplastic transformation, and how we might combat these processes clinically.
Jamie Rigney +3 more
doaj +1 more source
Isocitrate Dehydrogenase Mutations in Cancer: From Bench to Bedside Applications
MedComm, Volume 7, Issue 5, May 2026.Mutant isocitrate dehydrogenase affects multiple cancer types. Alterations in IDH1 and IDH2 result in abnormal enzyme activity, leading to the overproduction of D‐2‐hydroxyglutarate (D‐2HG). This metabolite disrupts cellular metabolism and epigenetic regulation, driving cancer initiation, progression, and metastasis.
Yuhan Fang +6 more
wiley +1 more source
Hematology, Transfusion and Cell TherapyPrimary effusion lymphoma (PEL) is an aggressive and rare type of diffuse large B-cell lymphoma (DLBL) that commonly presents itself as pleural, pericardial or peritoneal effusion without lymph node or extranodal involvement in immunosuppressed patients,
Vitor Abreu de Goes +4 more
doaj +1 more source
Pleuritis Induced by Brigatinib During the Treatment of Non‐Small Cell Lung Cancer
Respirology Case Reports, Volume 14, Issue 5, May 2026.This is the first reported case of brigatinib‐induced pleuritis in ALK‐positive lung cancer. Pleural effusion resolved after discontinuation and did not recur at a reduced dose of 30 mg/day. Dose reduction to 30 mg/day could be a safe and effective management strategy in selected patients.
Shohei Yano +7 more
wiley +1 more source
Journal of Research in Medical Sciences, 2014 This study describes a rare case of Human Immunodeficiency Virus and Human Herpes Virus 8 (HHV-8) negative primary effusion lymphoma (PEL)-like lymphoma in a patient with hepatitis B virus-related liver cirrhosis, diagnosed in a 66-year-old male who ...
He-Bin Fan +7 more
doaj
Case Reports in Oncological Medicine, 2014 Primary effusion lymphoma (PEL) or body cavity lymphoma is a rare type of extra nodal lymphoma of B-cell origin that presents as lymphomatous effusion(s) without any nodal enlargement or tumor masses. It belongs to the group of AIDS related non-Hodgkin’s
Farhan Mohammad +5 more
doaj +1 more source